Targeting the heat shock protein 90 dimer with dimeric inhibitors.


The design, synthesis, and biological evaluation of conformationally constrained coumermycin A1 analogues are reported. Compounds were evaluated against both breast cancer (SKBr3 and MCF7) and prostate cancer (PC3 mm2, A549, and HT29) cell lines. Non-noviosylated coumermycin A1 analogues that manifest potent antiproliferative activity resulting from Hsp90… (More)
DOI: 10.1021/jm200553w


6 Figures and Tables